CARDIOVASCULAR JOURNAL OF AFRICA • Vol 23, No 10, November 2012
AFRICA
545
6.
Webster G, Berul CI. Congenital long-QT syndromes: a clinical and
genetic update from infancy through adulthood.
Trends Cardiovasc
Med
2008;
18
: 216–224.
7.
Jamshidi Y, Nolte IM, Spector TD, Snieder H. Novel genes for QTc
interval. How much heritability is explained, and how much is left to
find?
Genome Med
2010;
2
: 35.
8.
Crotti L, Monti MC, Insolia R,
et al
.
NOS1AP is a genetic modifier of
the long-QT syndrome.
Circulation
2009;
120
: 1657–1663.
9.
Arking DE, Pfeufer A, Post W. A common genetic variant in the NOS1
regulator NOS1AP modulates cardiac repolarisation.
Nature Genet
2006;
38
: 644–651.
10.
Dekker JM, Crow RS, Hannan PJ,
et al
.
Heart rate-corrected QT
interval prolongation predicts risk of coronary heart disease in black
and white middle-aged men and women - the ARIC study.
J Am Coll
Cardiol
2004;
43
: 565–571.
11.
De Bruyne MC, Hoes AW, Kors JA,
et al
.
Prolonged QT interval
predicts cardiac and all-cause mortality in the elderly. The Rotterdam
Study.
Eur Heart J
1999;
20
: 278–284.
12.
Karjalainen J, Reunanen A, Ristola P, Viitasalo M. QT interval as
a cardiac risk factor in a middle aged population.
Heart
1997;
77
:
543–548.
13.
Crow RS, Hannan PJ, Folsom AR. Prognostic significance of corrected
QT and corrected JT interval for incident coronary heart disease in a
general population sample stratified by presence or absence of wide
QRS complex: the ARIC study with 13 years of follow-up.
Circulation
2003;
108
: 1985–1989.
14.
Lee J, Yoo K, Oh Y,
et al
.
Relationship between resting electrocar-
diographic parameters and estimated 10-year risk for coronary heart
disease in healthy adults in the USA.
Ann Noninvas Electrocardiol
2010;
15
: 315–320.
15.
Attar MN, Wong K, Groves DG,
et al
.
Clinical implications of QRS
duration and QT peak prolongation in patients with suspected coronary
disease referred for elective cardiac catheterization.
Ann Noninvas
Electrocardiol
2008;
13
: 106–102.
16.
Chugh S, Reinier K, Singh T,
et al
.
Determinants of prolonged QT
interval and their contribution to sudden death risk in coronary artery
disease: the Oregon sudden unexpected death study.
Circulation
2009;
119
: 663–670.
17.
Ouzounian M, Lee DS, Liu PP. Diastolic heart failure: mechanisms and
controversies.
Nature Clin Prac Cardiovasc Med
2008;
5
: 375–386.
18.
Valera-Roman A, Gonzalez-Juanatey JR, Basante P,
et al
.
Clinical char-
acteristics and prognosis of hospitalised inpatients with heart failure
and preserved or reduced left ventricular ejection fraction.
Heart
2002;
88
: 249–254.
19.
Swynghedauw B, Baillard C, Milliez P. The long QT interval is not
only inherited but is also linked to cardiac hypertrophy.
J Mol Med
2003;
81
: 336–345.
20.
Krämer B, Brill M, Brühn. A relationship between the degree of coro-
nary artery disease and of left ventricular function and the duration of
the QT-interval in ECG.
Eur Heart J
1986;
7
: 14–24.
21.
Pappachan JM, Sebastian J, Bino BC,
et al
.
Cardiac autonomic
neuropathy in diabetes mellitus: prevalence, risk factors and utility of
corrected QT interval in the ECG for its diagnosis.
Postgrad Med J
2008;
84
: 205–210.
22.
Klupa T, Mroczek T, Galicka-Latała D,
et al
.
Corrected QT interval and
diabetic neuropathy of the cardiovascular system.
Przegl Lek
1995;
52
:
583–587 (
abstract).
23.
Bravenboer B, Hendriksen PH, Oey LP,
et al
.
Is the corrected QT inter-
val a reliable indicator of the severity of diabetic autonomic neuropa-
thy?
Diabetes Care
1993;
16
: 1249–1253.
24.
Singh K. Effect of smoking on QT interval, QT dispersion and rate
pressure product.
Ind Heart J
2004;
56
: 140–142.
25.
Das G. QT interval and repolarization time in patients with intraven-
tricular conduction delay.
J Electrocardiol
1990;
23
: 49–52.
26.
Piotrowicz K, Zareba W, McNitt S, Moss AJ. Repolarization duration in
patients with conduction disturbances after myocardial infarction.
Am J
Cardiol
2007;
99
: 163–168.
27.
Resnick HE, Foster GL, Bardsley J, Ratner RE. Achievement of
American Diabetes Association clinical practice recommendations
among U.S. adults with diabetes, 1992–2002: the National Health and
Nutrition Examination Survey.
Diabetes Care
2006;
29
: 531– 537.
28.
Grundy SM, Cleeman JI, Merz CNB,
et al
.
National Cholesterol
Education Program (NCEP). Implications of recent clinical trials for
the National Cholesterol Education Program Adult Treatment Panel III
Guidelines.
Circulation
2004;
110
: 227–239.
29.
Truong QA, Banerji D, Ptaszek LM,
et al
.
Utility of nonspecific resting
electrocardiographic features for detection of coronary artery steno-
sis by Computed Tomography in acute chest pain patients: from the
ROMICAT trial.
Int J Cardiovasc Imaging
2011, 2
Feb. [Epub ahead
of print]
30.
Lang RM, Bierig M, Devereux RB,
et al
.
Recommendations for cham-
ber quantification.
Eur J Echocardiogr
2006;
7
: 79–108.
31.
Krämer B, Brill M, Brühn A, Kübler W. Relationship between the
degree of coronary artery disease and of left ventricular function and
the duration of the QT-interval in ECG.
Eur Heart J
1986;
7
: 14–24.
32.
Qi X, Yeh YH, Chartier D,
et al
.
The calcium/calmodulin/kinase
system and arrhythmogenic afterdepolarizations in bradycardia-related
acquired long-QT syndrome.
Circ Arrhythm Electrophysiol
2009;
2
:
295–304.
33.
Bardy GH, Lee KL, Mark DB,
et al
.
Amiodarone or an implantable
cardioverter-defibrillator for congestive heart failure.
N Engl J Med
2005;
352
: 225–237.
34.
Hu C, Yan C, Lin J, Liu S, Li Y. Down-regulation of the human ether-
a-go-go-related gene in rat cardiac hypertrophy.
Am J Med Sci
2011;
341
: 119–125.
35.
Lee TM, Lin MS, Chou TF, Chang NC. Effect of simvastatin on left
ventricular mass in hypercholesterolemic rabbits.
Am J Physiol Heart
Circ Physiol
2005;
288
:
H1352–1358.
